Company: INKT
Filing Date: 2025-12-10
Form Type: S-3/A
Source: 0001193125-25-314252
Chunk: 22

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-12-10
Form: S-3/A
Chunk 22
---
. Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be described in the applicable warrant agreements and the applicable prospectus supplement for the warrants. The applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the warrants:

| • |     | the specific designation and aggregate number of, and the price at which we will issue, the warrants; |

| • |     | the currency or currency units in which the offering price, if any, and the exercise price are payable; |

| • |     | the designation, amount and terms of the securities purchasable upon exercise of the warrants; |

| • |     | if applicable, the exercise price for our common stock and the number of common stock to be received upon 
 exercise of the warrants;                                                                                 |

| • |     | if applicable, the exercise price for our preferred stock, the number of preferred stock to be received upon 
 exercise of the warrants, and a description of that series of our preferred stock;                           |

| • |     | if applicable, the exercise price for our debt securities, the amount of our debt securities to be received upon 
 exercise of the warrants, and a description of that series of debt securities;                                   |

| • |     | the date on which the right to exercise the warrants will begin and the date on which that right will expire or,                             
 if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; |

| • |     | whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in                                                                    
 any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; |

| • |     | any applicable material U.S. federal income tax consequences; |

| • |     | the identity of the warrant agent for the warrants, if any, and of any other depositaries, execution or paying 
 agents, transfer agents, registrars or other agents;                                                           |

| • |     | the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any 
 securities exchange or market;                                                                                   |

| • |     | if applicable, the date from and after which the warrants and the common stock, preferred stock or debt 
 securities will be separately